Rahul D. Ballal is Director of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 7,992 shares of AGIO, which is worth approximately $459,619. The most recent transaction as insider was on Nov 08, 2024, when has been sold 10,000 shares (Common Stock) at a price of $58.34 per share, resulting in proceeds of $583,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.99K
0% 3M change
247.18% 12M change
Total Value Held $459,619

Rahul D. Ballal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 08 2024
SELL
Open market or private sale
$583,400 $58.34 p/Share
10,000 Reduced 55.58%
7,992 Common Stock
Nov 08 2024
BUY
Exercise of conversion of derivative security
$259,899 $25.99 p/Share
10,000 Added 35.72%
17,992 Common Stock
Nov 07 2024
SELL
Open market or private sale
$538,700 $53.87 p/Share
10,000 Reduced 55.58%
7,992 Common Stock
Nov 07 2024
BUY
Exercise of conversion of derivative security
$259,899 $25.99 p/Share
10,000 Added 35.72%
17,992 Common Stock
Aug 11 2024
BUY
Exercise of conversion of derivative security
-
2,302 Added 22.36%
7,992 Common Stock
Jun 13 2024
BUY
Exercise of conversion of derivative security
-
3,388 Added 37.32%
5,690 Common Stock
Aug 11 2023
BUY
Exercise of conversion of derivative security
-
2,302 Added 50.0%
2,302 Common Stock

Also insider at

IMRA
IMARA Inc. Healthcare
RDB

Rahul D. Ballal

Director
Cambridge, MA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO